Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3706929012 | Calcitonin gene-related peptide receptor antagonist (disposition) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3706930019 | Calcitonin gene-related peptide receptor antagonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3706934011 | CGPR antagonist | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 7529071000172117 | CGPR-antagonist | nl | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Belgian module (core metadata concept) |
| 7529081000172119 | calcitonine-gen-gerelateerd peptide-receptorantagonist | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Calcitonin gene-related peptide receptor antagonist (disposition) | Is a | Receptor antagonist (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some | |
| Erenumab | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some | |
| Fremanezumab (substance) | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some | |
| Galcanezumab | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some | |
| Ubrogepant (substance) | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some | |
| Rimegepant | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some | |
| Eptinezumab (substance) | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some | |
| Rimegepant sulfate | Has disposition (attribute) | True | Calcitonin gene-related peptide receptor antagonist (disposition) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR